Study protocol published in the internationally recognized peer-reviewed journal Trials (Springer Nature/BMC) Multicenter, randomized controlled trial at 10 centers in Germany, Poland, and Spain involving over 200 patients Further step in the clinical development of HyProtect™-coated revision implan
/INS . Product launch of new animal care products at the end of April at the North American Veterinary Dermatology Forum (NAVDF) Multiplier effect through professional audience throughout North America Number of Bio-Gate customers in North America increased Nuremberg/Bremen, April 24, 2025 - Bio-Gat
/INS . Project partner launches study for CE approval of implants coated with HyProtect TM Unique selling proposition due to extremely low infection rate Prevention of implant-associated infections HyProtect TM technology is able to solve prevalent and recurring problems in the field of infection pr
/INS. Nuremberg/Bremen, August 2, 2023 - Bio-Gate AG (ISIN DE000BGAG981), a leading provider of innovative technologies and individual solutions for health and hygiene, has concluded a preliminary agreement (LOI, Letter-of-Intent) with a North American medical device manufacturer focusing on the tra
Stronger and expanded international market access of OSSIS after acquisition by Zimmer Biomet Increased awareness of HyProtect™ coatings Increased volume of HyProtect™ coated implants
Medical technology business further strengthened Coating of orthopaedic revision implants with HyProtect technology Focus on protection against infections with multi-resistant germs Nuremberg/Bremen, 5 July 2022 – Bio-Gate AG (ISIN DE000BGAG981), a leading provider in the field of innovative health
Entry into another growth market through cooperation with Avicanna Inc. (TSX: AVCN) Products with synergistic properties of MicroSilver BG and CBD (hemp derived) have been developed. Addressing dermatology and cosmetics markets with an initial focus on North America and Europe Nuremberg/Bremen, June
/ins Protective Film Spray from Bio-Gate used for the first time in public transport in Nuremberg Advanced negotiations with further potential customers Successful commercialization for use in schools, public transport, banks and fitness studios
HyProtect TM - Focus on the antimicrobial coating of revision implants for knee and hip care in human medicine Aesculap can start the regulatory approval process for certain implants Broad international scope of cooperation
/ins Tested products are already available on the market Additional new products with antiviral effects soon to be launched Bio-Gate products suitable for extending existing hygiene strategies
Showing 1–10 of 13